Novel arylcycloalkanepolyalkylamines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142375, 5142378, 5142382, 5142388, 514317, 514319, 514320, 514323, 514326, 514422, 514423, 514424, 514427, 544158, 544160, 544161, 544164, 548527, 548530, 548537, 548538, 548539, 548541, 548542, 548543, 548205, 548198, 548196, 548201, 546208, 546212, A61K 31445, A61K 3133, C07D26530, C07D29522, C07D21106

Patent

active

050860542

ABSTRACT:
Novel arylcycloalkanepolyalkylamines useful as anti-psychotic, anti-ischemia, anti-stroke, anti-dementia and anti-convulsant agents. These arylcycloalkanepolyalkylamines are selective high-affinity ligands to the sigma binding-sites containing three basic units: arylcycloalkyl group, an amine group and an intermediate chain. Their preparation and use for treatment of psychoses, ischemia, stroke, dementia and convulsions are also disclosed.

REFERENCES:
patent: 4634713 (1987-01-01), Werner et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Novel arylcycloalkanepolyalkylamines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel arylcycloalkanepolyalkylamines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel arylcycloalkanepolyalkylamines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-348113

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.